drugset / Trial / NCT05208333

The Effectiveness of Albendazole Treatment Among Infected Toxocara Children

NCT05208333

NaSingle-groupOpen-labelTreatment

Summary

This study consists 2 phases. The first phase will conduct a cross-sectional study to determine the infection rate of Toxocariasis larvae, describe the clinical and paraclinical characteristics, identify risk factors related to Toxocariasis larva infection. The second phase will conduct an interventional study to evaluate the effectiveness and factors related to the Albendazole treatment on pupils infected with Toxocariasis larvae in Ho Chi Minh City.

Timeline

Start
2022-05
Primary completion
2023-12
Completion
2024-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule 15 mg/kg

Indications